A portable graphical link to your paper (QR code) is provided below. If the code is placed, for example, on a poster, your paper can be accessed through a mobile device's QR code reader.

Right click on the image below to save it to your device.

QR Code for 10.1101/2024.02.11.24302594

A Phase II Study Integrating a Single-Blind Safety Phase with a Double-Blind, Placebo-Controlled Randomized Phase, Assessing Single-Dose Intramuscular or Intranasal Administration to Evaluate the Safety and Immunogenicity of the Recombinant Vaccine Against COVID-19 (AVX/COVID-12 "Patria") Based on an Active Newcastle Disease Viral Vector as a Heterologous Booster in Subjects with Evidence of Previous Immunity to SARS-CoV-2.